Determining the brain perfusion is an important task for diagnosis of vascular diseases such as occlusions and intracerebral haemorrhage. Even after successful diagnosis, there is a high risk of restenosis or rebleeding such that patients need intense attention in the days after treatment. Within this work, we present a diagnostic tomographic imager that allows access to brain perfusion quantitatively in short intervals. The device is based on the magnetic particle imaging technology and is designed for human scale. It is highly sensitive and allows the detection of an iron concentration of 263 pmol
Fe
ml
−1
, which is one of the lowest iron concentrations imaged by MPI so far. The imager is self-shielded and can be used in unshielded environments such as intensive care units. In combination with the low technical requirements this opens up a variety of medical applications and would allow monitoring of stroke on intensive care units.
After realizing the worlds' first preclinical magnetic particle imaging (MPI) demonstrator, Philips is now realizing the worlds' first whole-body clinical prototype to prove the feasibility of MPI for clinical imaging. After a brief introduction of the basic MPI imaging process, this contribution presents an overview on the determining factors for key properties, i.e., spatial resolution, acquisition speed, sensitivity, and quantitativeness, and how these properties are influenced by scaling up from preclinical to clinical instrumentation. Furthermore, it is discussed how this scale up affects the physiological compatibility of the method as well as hardware parameters such as power requirements for drive field generation, selection and focus field generation, and the design of the receive chain of the MPI device.
Magnetic Particle Imaging (MPI) is a high-potential new medical imaging modality that has been introduced in 2005.MPI uses the non-linear magnetization behavior of iron-oxide based nano-particles, named tracer, to perform quantitative measurements of their local concentration. Previous publications demonstrated the feasibility of real-time in vivo 3D imaging with clinical concentration of Resovist®. Given MPI's fast and sensitive imaging as well as its overall versatility, it has potential to support various medical applications spanning from diagnostics to therapy. As an example, ongoing research investigates the use of MPI in cardiovascular diagnostics for myocardial perfusion measurement.While previous publications reported results from experimental systems with limited bore size (3cm), this contribution presents first phantom and in vivo images acquired on the next hardware generation, an experimental system with an effective bore size of 12cm. The system is designed for pre-clinical studies and can capture image data from an extended field of view compared to the previous, experimental system. The contribution introduces concepts for the encoding of a larger field of view by means of additional magnetic fields, named focus-fields, and outlines the path to stitching of images from multiple focus field settings, called "multi-station reconstruction". To prove the feasibility of imaging of an extended field of view, volumetric images of a moving phantom as well as of a living rat were acquired.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.